Laboratories should not disclose their GenQA participant codes (or previous CEQAS or UK NEQAS for Molecular Genetics codes, where relevant) to third parties. EQA submissions data and performance scores are confidential between the individual laboratory and GenQA.

Information on whether a laboratory participates in GenQA or a specific EQA will be disclosed to Orphanet database and other EQA related bodies. The unique laboratory code, raw data or performance will not be disclosed to these bodies. A laboratory can specifically request that the participation information is not disclosed; this request has to be made in writing to the Scheme Directors.

GenQA offers a number of EQAs in collaboration with other EQA providers such as EMQN, IQN Path, NHS England, Genomics England, UK NEQAS LI and UK NEQAS IHC & ISH. In order to maintain performance monitoring for laboratories potentially alternately registering with either of these providers, the identity of laboratories with poor performance and persistent poor performance may be shared between the Scheme Directors or NHS England and Genomics England representatives if applicable.

Individual laboratory performance scores, in anonymised form, may be shared with local management, accrediting bodies, and suppliers of equipment and reagents where appropriate and necessary, but only with the participant's explicit permission. 

The standard of performance of all English laboratories performing molecular newborn screening for cystic fibrosis and/or medium chain acyl-CoA dehydrogenase deficiency will be disclosed to the Newborn Screening Committee by GenQA. By enrolling in these EQAs the laboratory is agreeing to this disclose of performance.

If deemed appropriate by the GenQA Directors, participation and performance data may be shared with collaborating EQA providers in order to prevent ‘Scheme Hopping’ due to Poor Performance.

Last updated: Tuesday, 03 December 2019
Go to top